Related Experiment Video
Updated: Aug 9, 2026
06:28
E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Constipation related to narcotic therapy. A protocol for nurses and patients
1Rhode Island Hospital, Providence 02903.
Cancer Nursing
|October 1, 1992
Summary
Narcotic-induced constipation is a common issue for cancer patients. Proactive nursing care, including senna derivatives and lifestyle education, is crucial for prevention and patient comfort.
Area of Science:
- Oncology Nursing
- Gastroenterology
- Pharmacology
Background:
- Constipation is a significant side effect of narcotic pain medication, particularly in cancer patients.
- Limited literature exists on narcotic-induced constipation, potentially due to vague definitions and underestimation of its severity by healthcare providers.
- While focusing on narcotic-induced constipation, other contributing factors like diet, exercise, and underlying diseases are acknowledged.
Purpose of the Study:
- To highlight the importance of addressing narcotic-induced constipation in cancer care.
- To emphasize nursing's role in preventing constipation.
- To recommend specific preventive strategies.
Main Methods:
- Review of existing literature on narcotic-induced constipation.
- Discussion of pharmacological interventions, specifically senna derivatives.
- Proposal of a nursing care protocol for constipation prevention.
Main Results:
- Senna derivatives can counteract the colon's decreased propulsive movements caused by narcotics.
- Preventive measures are more effective than treatment for managing constipation.
- A structured protocol integrating medication, patient education, and daily monitoring is effective.
Conclusions:
- Nursing care should prioritize the prevention of constipation in patients using narcotics.
- Senna derivatives should be administered concurrently with narcotics as a preventive measure.
- Implementing a comprehensive protocol enhances nurses' ability to prevent constipation and improve patient comfort.
Related Concept Videos
01:22Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
01:20Drugs Affecting GI Tract Motility: Other Laxatives
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.